Lv1
20 积分 2026-02-26 加入
Fruquintinib: First Global Approval
13天前
已完结
Enhancing trust and interpretability of complex machine learning models using local interpretable model agnostic shap explanations
6个月前
已完结
Neural multi-task learning in drug design
6个月前
已完结
The challenges of generalizability in artificial intelligence for ADME/Tox endpoint and activity prediction
6个月前
已完结
Perspectives on the use of machine learning for ADME prediction at AstraZeneca
6个月前
已完结
皖公网安备34019202002308
